- Home
- RVMD
as 11-21-2024 10:38am EST
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 10.2B | IPO Year: | 2020 |
| Target Price: | $57.00 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $20.86 - $62.40 | Next Earning Date: | 11-06-2024 |
| Revenue: | $742,000 | Revenue Growth: | -97.16% |
| Revenue Growth (this year): | -97.36% | Revenue Growth (next year): | 300.00% |
Latest Revolution Medicines Inc. News
RVMD Breaking Stock News: Dive into RVMD Ticker-Specific Updates for Smart Investing
GuruFocus.com
12 days ago
Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insight
MT Newswires
14 days ago
Revolution Medicines Q3 Loss Narrows; Reaffirms Full-Year Guidance
GuruFocus.com
14 days ago
Revolution Medicines Inc (RVMD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
GlobeNewswire
15 days ago
Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress
MT Newswires
16 days ago
Revolution Medicines Insider Sold Shares Worth $3,878,773, According to a Recent SEC Filing
GlobeNewswire
16 days ago
Revolution Medicines to Participate in Upcoming Investor Conferences
GuruFocus.com
16 days ago
Revolution Medicines Inc (RVMD) Q3 2024 Earnings Report Preview: What To Look For
GlobeNewswire
22 days ago
Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024
Compare RVMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RVMD Revolution Medicines Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.